HC Wainwright & Co. Reiterates Neutral on Spruce Biosciences
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Neutral rating on Spruce Biosciences (NASDAQ:SPRB).
June 05, 2024 | 11:21 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated its Neutral rating on Spruce Biosciences, indicating no change in their outlook for the company.
The reiteration of a Neutral rating suggests that the analyst sees no significant positive or negative changes in the company's prospects. This is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100